PLX READ THE FULL PLX RESEARCH REPORT Protalix BioTherapeutics, Inc. (NYSE:PLX) announced a collaboration with the Germany-based Secarna Pharmaceuticals to develop novel antisense oligonucleotide (ASO ...

Partnership combines Protalix's rare disease and biologics expertise with Secarna's AI–powered OligoCreator® platform to ...

Here’s a summary of the most significant insider transactions disclosed on Tuesday for U.S. publicly traded companies. Top ...

BioMarin Pharmaceutical’s strong rare disease drug portfolio and Amicus acquisition drive a ‘Buy’ rating. Click here to read my latest analysis of BMRN stock.

After a brief pause, gold is back on the rise. On Tuesday, it climbed above the $4,300 per ounce mark again, partly thanks to the weakness of the US dollar. When might we see new ...

News headlines Unity Software (U) has experienced significant stock volatility, driven by recent inflation reports and insider selling. Analysts remain divided, with some suggesting the stock may be ...

1 Day HII 5.01% DJIA 0.47% S&P 500 0.64% Industrial Goods 1.50% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and ...

Sign up for Essential California for the L.A. Times biggest news, features and recommendations in your inbox six days a week. eNewspaper Find/Post Jobs Place an Ad ...